Arno de Wilde

1.6k total citations
21 papers, 912 citations indexed

About

Arno de Wilde is a scholar working on Psychiatry and Mental health, Physiology and Economics and Econometrics. According to data from OpenAlex, Arno de Wilde has authored 21 papers receiving a total of 912 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Psychiatry and Mental health, 13 papers in Physiology and 4 papers in Economics and Econometrics. Recurrent topics in Arno de Wilde's work include Dementia and Cognitive Impairment Research (14 papers), Alzheimer's disease research and treatments (12 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Arno de Wilde is often cited by papers focused on Dementia and Cognitive Impairment Research (14 papers), Alzheimer's disease research and treatments (12 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Arno de Wilde collaborates with scholars based in Netherlands, United Kingdom and Sweden. Arno de Wilde's co-authors include Philip Scheltens, Wiesje M. van der Flier, Frederik Barkhof, Bart N.M. van Berckel, Marissa D. Zwan, Femke H. Bouwman, Rik Ossenkoppele, Charlotte E. Teunissen, Andrew Stephens and Malcolm Macleod and has published in prestigious journals such as Neurology, PLoS Biology and Neurosurgery.

In The Last Decade

Arno de Wilde

21 papers receiving 900 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arno de Wilde Netherlands 14 404 396 147 98 97 21 912
Liyong Wu China 16 242 0.6× 297 0.8× 135 0.9× 129 1.3× 190 2.0× 73 763
Akinori Takeda Japan 18 221 0.5× 512 1.3× 237 1.6× 173 1.8× 157 1.6× 78 1.3k
Xinyu Fang China 23 323 0.8× 106 0.3× 306 2.1× 123 1.3× 237 2.4× 96 1.5k
Michael Brainin Austria 7 171 0.4× 160 0.4× 213 1.4× 149 1.5× 91 0.9× 11 1.2k
Nina Silverberg United States 12 198 0.5× 336 0.8× 132 0.9× 101 1.0× 186 1.9× 19 839
Ekaterina Manuilova Russia 13 408 1.0× 447 1.1× 249 1.7× 94 1.0× 98 1.0× 47 864
Karamarie Fecho United States 21 170 0.4× 398 1.0× 385 2.6× 63 0.6× 55 0.6× 58 1.4k
Allitia DiBernardo United States 21 399 1.0× 219 0.6× 175 1.2× 212 2.2× 163 1.7× 45 1.4k
Justin L. Hay Netherlands 18 61 0.2× 295 0.7× 192 1.3× 21 0.2× 134 1.4× 46 813
Elizabeth A. Garofalo United States 18 1.0k 2.5× 509 1.3× 214 1.5× 29 0.3× 301 3.1× 20 1.9k

Countries citing papers authored by Arno de Wilde

Since Specialization
Citations

This map shows the geographic impact of Arno de Wilde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arno de Wilde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arno de Wilde more than expected).

Fields of papers citing papers by Arno de Wilde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arno de Wilde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arno de Wilde. The network helps show where Arno de Wilde may publish in the future.

Co-authorship network of co-authors of Arno de Wilde

This figure shows the co-authorship network connecting the top 25 collaborators of Arno de Wilde. A scholar is included among the top collaborators of Arno de Wilde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arno de Wilde. Arno de Wilde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vermunt, Lisa, Arno de Wilde, Philip Scheltens, et al.. (2024). Utilization of fluid-based biomarkers as endpoints in disease-modifying clinical trials for Alzheimer’s disease: a systematic review. Alzheimer s Research & Therapy. 16(1). 93–93. 7 indexed citations
2.
Maurik, Ingrid S. van, Arno de Wilde, Femke H. Bouwman, et al.. (2022). A more precise diagnosis by means of amyloid PET contributes to delayed institutionalization, lower mortality, and reduced care costs in a tertiary memory clinic setting. Alzheimer s & Dementia. 19(5). 2006–2013. 21 indexed citations
3.
Collij, Lyduine E., Gemma Salvadó, Arno de Wilde, et al.. (2022). Quantification of [18F]florbetaben amyloid‐PET imaging in a mixed memory clinic population: The ABIDE project. Alzheimer s & Dementia. 19(6). 2397–2407. 13 indexed citations
4.
Bokhoven, Pieter van, Arno de Wilde, Lisa Vermunt, et al.. (2021). The Alzheimer’s disease drug development landscape. Alzheimer s Research & Therapy. 13(1). 186–186. 64 indexed citations
5.
Galvin, James E., Paul Aisen, Jessica B. Langbaum, et al.. (2021). Early Stages of Alzheimer's Disease: Evolving the Care Team for Optimal Patient Management. Frontiers in Neurology. 11. 592302–592302. 34 indexed citations
6.
Verberk, Inge M.W., Elisabeth H. Thijssen, Kimberley Mauroo, et al.. (2020). Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology. Alzheimer s Research & Therapy. 12(1). 118–118. 163 indexed citations
7.
Reimand, Juhan, Arno de Wilde, Charlotte E. Teunissen, et al.. (2019). PET and CSF amyloid-β status are differently predicted by patient features: information from discordant cases. Alzheimer s Research & Therapy. 11(1). 100–100. 18 indexed citations
8.
Altomare, Daniele, Arno de Wilde, Rik Ossenkoppele, et al.. (2019). Applying the ATN scheme in a memory clinic population. Neurology. 93(17). e1635–e1646. 47 indexed citations
9.
Wilde, Arno de, Juhan Reimand, Charlotte E. Teunissen, et al.. (2019). Discordant amyloid-β PET and CSF biomarkers and its clinical consequences. Alzheimer s Research & Therapy. 11(1). 78–78. 30 indexed citations
10.
Maurik, Ingrid S. van, Arno de Wilde, Femke H. Bouwman, et al.. (2019). Added value of amyloid PET in individualized risk predictions for MCI patients. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 11(1). 529–537. 10 indexed citations
11.
Wilde, Arno de, Rik Ossenkoppele, Wiesje Pelkmans, et al.. (2019). Assessment of the appropriate use criteria for amyloid PET in an unselected memory clinic cohort: The ABIDE project. Alzheimer s & Dementia. 15(11). 1458–1467. 16 indexed citations
12.
Wilde, Arno de, Marieke van Buchem, René H.J. Otten, et al.. (2018). Disclosure of amyloid positron emission tomography results to individuals without dementia: a systematic review. Alzheimer s Research & Therapy. 10(1). 72–72. 46 indexed citations
13.
Wilde, Arno de, Paut Greebe, Gabriël J.E. Rinkel, & Ale Algra. (2018). Stress in Patients With (Un)ruptured Intracranial Aneurysms vs Population-Based Controls. Neurosurgery. 84(5). 1065–1071. 9 indexed citations
14.
Wilde, Arno de, Wiesje M. van der Flier, Wiesje Pelkmans, et al.. (2018). Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort. JAMA Neurology. 75(9). 1062–1062. 95 indexed citations
15.
Vaucher, Julien, Michael V. Holmes, Arno de Wilde, et al.. (2017). Genetic variants associated with type 2 diabetes and adiposity and risk of intracranial and abdominal aortic aneurysms. European Journal of Human Genetics. 25(6). 758–762. 14 indexed citations
16.
Wilde, Arno de, Ingrid S. van Maurik, Marleen Kunneman, et al.. (2017). Alzheimer's biomarkers in daily practice (ABIDE) project: Rationale and design. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 6(1). 143–151. 55 indexed citations
17.
Macleod, Malcolm, Aaron Lawson McLean, Aikaterini Kyriakopoulou, et al.. (2015). Risk of Bias in Reports of In Vivo Research: A Focus for Improvement. PLoS Biology. 13(10). e1002273–e1002273. 239 indexed citations
18.
Nieuwkamp, Dennis J., Arno de Wilde, Marieke J.H. Wermer, Ale Algra, & Gabriël J.E. Rinkel. (2013). Long-term outcome after aneurysmal subarachnoid hemorrhage—risks of vascular events, death from cancer and all-cause death. Journal of Neurology. 261(2). 309–315. 20 indexed citations
19.
England, R. J., et al.. (1996). The posterior cricoarytenoid ligaments and their relationship to the cadaveric position of the vocal cords. Clinical Otolaryngology. 21(5). 425–428. 4 indexed citations
20.
Jones, A. S., et al.. (1994). The treatment of early squamous cell carcinoma of the piriform fossa. Clinical Otolaryngology. 19(6). 485–490. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liyong Wu Breakdown of academic impact, for papers by Akinori Takeda Breakdown of academic impact, for papers by Xinyu Fang Breakdown of academic impact, for papers by Michael Brainin Breakdown of academic impact, for papers by Nina Silverberg Breakdown of academic impact, for papers by Ekaterina Manuilova Breakdown of academic impact, for papers by Karamarie Fecho Breakdown of academic impact, for papers by Allitia DiBernardo Breakdown of academic impact, for papers by Justin L. Hay Breakdown of academic impact, for papers by Elizabeth A. Garofalo
Rankless by CCL
2026